Summary
Danaher Corporation (DHR) filed an 8-K on January 13, 2020, to provide anticipated financial performance for the fourth quarter of 2019 ahead of its presentation at the J.P. Morgan Healthcare Conference. While the filing does not contain definitive Q4 2019 results, it signals management's intent to discuss performance and outlook. Investors should pay close attention to the J.P. Morgan Healthcare Conference presentation for specific financial details and forward-looking statements, as this 8-K serves primarily as a precursor to that event.
Key Highlights
- 1Danaher Corporation (DHR) released an 8-K on January 13, 2020, related to its anticipated Q4 2019 financial performance.
- 2The announcement precedes a scheduled presentation at the J.P. Morgan Healthcare Conference on January 14, 2020.
- 3The 8-K incorporates a press release titled 'Danaher CEO to Comment on Financial Performance'.
- 4This filing serves as a notification and a preliminary communication of financial expectations.
- 5Specific financial results for Q4 2019 are not detailed within this 8-K but are expected to be disclosed during the conference presentation.
- 6The information provided is not considered 'filed' for certain regulatory purposes until expressly incorporated into a future filing.